Bioworks anticipates commecialization of synthetic cultured rare cannabinoids by Q3.  Off the radar for many.  Been waiting 3 years for this to happen, now just a few months away.  Health Canada ought to issue the commercial processing license shortly if all is on track to meet production/commercialization targets, and things are on track per recent conf. call.  More attention to this business segment in the 4/26 Cantechletter featuring client report by Raymond James.

Transcript (2/26/21):

Cantechletter (4/26/21):